Stem cell therapy for multiple sclerosis (MS) includes autologous haemopoietic stem cell transplant (AHSCT). The aim of AHSCT is to rebuild your body’s immune system so that it no longer attacks your myelin or causes inflammation in your brain and spinal cord.

In a this blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. This is the final part where the results of the trial are in...

Star-MS is a phase 3 clinical trial comparing stem cell transplantation with highly active disease modifying drugs (DMDs) in multiple sclerosis (MS).

Sativex has been approved by SMC in Scotland as a cost effective treatment for moderate to severe MS spasticity.

We discuss HSCT for MS, hearing from Claire in the information team about the criteria for receiving stem cell transplantation. Our guests also include Chris who was eligible for HSCT on the NHS and Gwen who went to Russia to seek treatment for PPMS. Both share their experiences and give advice for anyone else considering the option.

We live in an information age. Now more than ever before we have ready access to an enormous quantity of data about health, treatments and research – from the internet, though the press, and on social media. But how we do know how to trust and understand what all this information is telling us? Simon from the MS Trust's Information Team has some tips to help you find health information you can trust.

When you have just been diagnosed with multiple sclerosis (MS), you will need to think about who to tell, when to tell them and how much to tell them.

Most people with MS receive their diagnosis during their working life. This episode covers what working life is like when you have multiple sclerosis. We discuss what rights people have at work, what to do when you feel like you have to give up work or reduce your hours, and much more.

Facing MS relapses and an unsupportive work situation, Lou’s MS nurse stood tall and fought her corner.